What is Medical Device Equivalence? A Detailed Guide

Medical device equivalence is a regulatory concept under the EU Medical Device Regulation (MDR). It allows a manufacturer to rely on the clinical data of an already marketed device to support the safety and performance of a new device. However, they must demonstrate that the two are sufficiently similar. Under EU MDR, equivalence must be demonstrated across three dimensions: technical, biological, and clinical characteristics. Thus, medical device equivalence saves significant time and cost by reducing the need for new trials. It streamlines regulatory approval, helping devices reach patients faster while still ensuring safety and performance standards are met. Simultaneously, it minimizes duplication of clinical investigations and reduces ethical concerns around unnecessary patient exposure.

What is medical device equivalence?

Medical device equivalence is used to prove a new device is sufficiently similar to an already legally marketed device so that the existing device’s clinical data can be used to support the safety and performance of the new one. To establish equivalence, the new device must match the marketed one across three dimensions: technical characteristics (design, specifications, and operating principles), biological characteristics (materials in contact with the body and their duration of exposure), and clinical characteristics (intended purpose, patient population, and conditions of use). If these similarities are proven and any differences are shown not to affect safety or performance, the manufacturer can use the existing clinical evidence instead of conducting new trials. This streamlines the path to CE marking and market approval.

Regulatory pathway

• EU MDR (Regulation (EU) 2017/745): The EU MDR establishes equivalence as part of the clinical evaluation process. Hence, it requires proof of similarity in technical, biological, and clinical characteristics. Article 61 and Annex XIV Part A specifically outline the conditions under which equivalence can be claimed.
• MDCG guidance (MDCG 2020-5): This guidance document clarifies how manufacturers should demonstrate equivalence, including the level of detail expected in comparisons. It emphasizes that equivalence must be proven to a single marketed device and not by combining features of multiple devices.
• Class III and implantable devices: For high-risk devices, stricter rules apply, often requiring contractual access to the equivalent device’s technical documentation. Without such access, notified bodies typically reject equivalence claims, thereby making new clinical investigations necessary.

What are the three dimensions of medical device equivalence?

Under EU MDR, medical device equivalence must be demonstrated across three dimensions: technical, biological, and clinical.

1. Technical equivalence: Technical equivalence means the devices share similar design, specifications, and operating principles. This includes aspects, like software algorithms, energy sources, and deployment methods. Even small differences must be analyzed to confirm they do not affect safety or performance. For example, two pacemakers with identical pacing algorithms and battery systems could be considered technically equivalent.
2. Biological equivalence: Biological equivalence focuses on the materials that come into contact with the human body. The devices must use the same or highly similar materials, with identical duration and nature of exposure. This ensures that biocompatibility risks, such as toxicity or allergic reactions, are comparable. For instance, catheters made from the same polymer and used for the same length of time in the bloodstream would meet biological equivalence.
3. Clinical equivalence: Clinical equivalence requires that the devices have the same intended purpose, patient population, and conditions of use. This means they must be used in the same anatomical location and for the same medical indications. Any differences must be justified as not clinically significant to patient outcomes. For example, two blood glucose monitors used for diabetic patients under identical conditions could be considered clinically equivalent.

5 Key requirements for equivalence

Key requirements for demonstrating medical device equivalence under EU MDR.

1. Single device reference: Equivalence must be demonstrated against one legally marketed device and not by combining features of multiple devices. This ensures clarity and avoids cherry-picking similarities from different products.
2. Three-dimensional similarity: Manufacturers must prove similarity in technical, biological, and clinical characteristics. Any differences must be scientifically justified as not impacting safety or performance.
3. Access to documentation: For Class III and implantable devices, manufacturers need contractual access to the equivalent device’s technical documentation. Without this, notified bodies typically reject equivalence claims.
4. Clinical evaluation documentation: Medical device equivalence arguments must be detailed in the Clinical Evaluation Plan (CEP) and Clinical Evaluation Report (CER). These documents provide structured evidence for notified body review.
5. Notified body scrutiny: Medical device equivalence claims are subject to rigorous examination by notified bodies. Weak or superficial claims often result in rejection and the requirement for new clinical investigations.

Process of demonstrating medical device equivalence

1. Identify the equivalent device: Manufacturers must select a legally marketed device (CE-marked in the EU) as the reference. It must be a single device and not a combination of features from multiple products.
2. Perform systematic comparison: A detailed, point-by-point analysis is conducted across technical, biological, and clinical characteristics. Any differences must be documented and scientifically justified as not affecting safety or performance.
3. Gather supporting evidence: Manufacturers need access to sufficient data on the equivalent device, including design specifications, materials, and clinical use. For Class III and implantable devices, contractual access to technical documentation is often required.
4. Document in clinical evaluation plan (CEP): The equivalence rationale is first outlined in the CEP, which sets the strategy for clinical evaluation. This ensures the approach is structured and aligned with MDR requirements.
5. Prepare clinical evaluation report (CER): The CER contains the detailed equivalence analysis, evidence, and justification. It is submitted to the notified body for review as part of the conformity assessment.
6. Notified body review: The notified body rigorously examines medical device equivalence claims, especially for high-risk devices. Weak or incomplete arguments often lead to rejection and the need for new clinical investigations.

How to know whether opting for equivalence is right for your device?

• Device risk class: For low- to medium-risk devices (Class I/IIa/IIb), equivalence is often a viable option if strong similarity can be demonstrated. For high–risk or implantable devices (Class III), equivalence is rarely accepted unless you have contractual access to the equivalent device’s technical documentation.
• Similarity across three dimensions: Your device must align closely with another marketed device in technical, biological, and clinical characteristics. Even minor differences must be justified with evidence showing they do not affect safety or performance.
• Access to data: You need sufficient information about the equivalent device, including design, materials, and clinical data. If you cannot obtain this documentation, equivalence will not be accepted. Moreover, new clinical investigations may be required.
• Regulatory strategy: Medical device equivalence can save time and cost by avoiding new trials. However, weak claims risk rejection and delays. A strong equivalence case strengthens your Clinical Evaluation Report (CER) and accelerates CE marking.

Therefore, opting for medical device equivalence is right if your device is not high-risk, you can prove similarity across all three dimensions, and you have access to sufficient documentation. If any of these conditions fail, pursuing new clinical data is safer and more compliant.

Why medical device equivalence matters?

Medical device equivalence is important because it provides a pathway for manufacturers to use existing clinical data from a similar marketed device. It reduces the need for costly and time-consuming new trials. This accelerates regulatory approval, helping safe and effective devices reach patients faster while maintaining compliance with EU MDR standards. It also minimizes duplication of clinical investigations, which reduces ethical concerns around exposing patients to unnecessary risks and supports efficient innovation in the medical device industry.

Navigating the EU MDR guidelines can be challenging. We at Pharmadocx Consultants have the expertise to help you have a smooth regulatory journey under the EU MDR framework. Drop an email at [email protected] or call/Whatsapp on 9996859227. Our team will help you opt for medical device equivalence if it is apt for your product.